Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01630499 · ClinicalTrials.gov registry record · NA

My Lifestyle Intervention of Food and Exercise

A NA study, sponsored by University of Florida.

Completed
Registry status
NA
Development phase
87
Enrollment target

NCT01630499: Completed NA study, sponsored by University of Florida.

NCT01630499 is a NA study that has completed, run by University of Florida. The registered enrollment target is 87 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01630499, a NA study, has completed, sponsored by University of Florida.

COMPLETED
Registry status
NA
Development phase
87 participants
Enrollment target

Study Summary

Breast cancer risk, and risk of related health problems (e.g., heart disease), is highest among women with a history of breast cancer (stages 1-3) who are also overweight or obese. The purpose of this study is to compare a tailored nutrition, physical activity, and behavioral weight management program for breast cancer survivors against a widely available commercial weight management program. We hypothesize that an intervention tailored to the unique psychological, nutritional and physical needs of breast cancer survivors will provide superior physiological and psychological benefits compared to an existing commercial program.

Interventions

  • BEHAVIORAL Tailored Lifestyle Intervention (TLI)
  • BEHAVIORAL Commercial Weight Loss Program (CWLP)

Trial Details

FieldValue
Enrollment Target 87 participants
Start Date 2012-10
Est. Completion 2016-07
Phase NA
University of Florida

1,106 total trials

What the finished NCT01630499 record still lists

NCT01630499 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 87 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 2 interventions - of which Tailored Lifestyle Intervention (TLI) is the first listed.

NCT01630499 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01630499 about?

NCT01630499 is a clinical study titled "My Lifestyle Intervention of Food and Exercise". Breast cancer risk, and risk of related health problems (e.g., heart disease), is highest among women with a history of breast cancer (stages 1-3) who are also overweight or obese. The purpose of this study is to compare a tailored nutrition, physical activity, and behavioral weight management progr...

What is the current status of trial NCT01630499?

This trial is currently completed. It is a NA study. The enrollment target is 87 participants. The study started on 2012-10. Estimated completion is 2016-07.

What interventions are being tested in trial NCT01630499?

The interventions under investigation include: Tailored Lifestyle Intervention (TLI) (BEHAVIORAL), Commercial Weight Loss Program (CWLP) (BEHAVIORAL).

Who is sponsoring clinical trial NCT01630499?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01630499's enrollment target sits among peer trials

87 974th of 2000 higher than 1,025 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03292601 · 87 participants · NA

    Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)

  • NCT04291105 · 87 participants · Phase 2

    Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

  • NCT04565795 · 87 participants · NA

    Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy

  • NCT05607004 · 87 participants · Phase 2

    (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01630499, the US trial registry maintained by the National Library of Medicine. NCT01630499 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.